These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 6273933)

  • 1. Current clinical concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
    [No Abstract]   [Full Text] [Related]  

  • 2. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-Rh0 (D) hemolytic disease of the newborn: an obstetric viewpoint.
    Zlatnik FJ
    Semin Perinatol; 1977 Apr; 1(2):169-75. PubMed ID: 754292
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-rhesus (D) blood group isoimmunization in obstetrics.
    Beal RW
    Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
    Adams MM; Gustafson J
    Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
    Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
    Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple maternal isoimmunization.
    Cardwell MS
    J Tenn Med Assoc; 1988 Jul; 81(7):435-6. PubMed ID: 3135450
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 9. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 11. Current concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Mt Sinai J Med; 1980; 47(5):454-60. PubMed ID: 6969353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Several problems of pregnancy complicated by blood group incompatibility].
    Noda K
    Nihon Hoigaku Zasshi; 1968 Jul; 22(4):339-50. PubMed ID: 4973992
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of Rh immune globulin.
    Gorman JG
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):422-6. PubMed ID: 5003518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of immunologic tests in the hemolytic disease of the newborn in ABO incompatibility].
    Kourteva B; Doitchinova N; Chinkov D
    Nouv Rev Fr Hematol; 1968; 8(6):892-4. PubMed ID: 4236876
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG; Meriggi E; De Martin G
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
    Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
    Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemolytic disease of the newborn due to anti-E. Case report].
    Schneider W; Dahl J vom
    Geburtshilfe Frauenheilkd; 1967 Sep; 27(9):900-3. PubMed ID: 4969211
    [No Abstract]   [Full Text] [Related]  

  • 18. [Materno-fetal incompatibility in the ABO system as a factor of protection against hemolytic disease caused by Rh incompatibility].
    Mollica F
    Minerva Pediatr; 1967 Mar; 19(13):610-1. PubMed ID: 4963996
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
    Monestier M; Rigal D; Juron-Dupraz F; Meyer F
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 50.